Pharmaceutical

Atossa Therapeutics progresses Phase II preventative breast cancer therapy

Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.

Jan 27, 2024 - 18:00
Atossa Therapeutics progresses Phase II preventative breast cancer therapy
Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans a Phase III preventative breast cancer trial.
Read the original article

Tags:

Previous Article

CAR-T therapies and cancer risk: No easy answers for the FDA

Next Article

FDA expands approval of Dupixent for eosinophilic esophagitis in children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Illegal online pharmacies gain traction as regulators lag behind

Illegal online pharmacies gain traction as regulators l...

May 26, 2023

National Resilience secures funding for domestic biomanufacturing capacity

National Resilience secures funding for domestic bioman...

Mar 27, 2023

Republicans aren’t quite done talking about Obamacare, after all

Republicans aren’t quite done talking about Obamacare, ...

Sep 28, 2023